{"id":29570,"date":"2016-02-01T12:09:34","date_gmt":"2016-02-01T12:09:34","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=29570"},"modified":"2016-02-05T11:34:19","modified_gmt":"2016-02-05T11:34:19","slug":"south-african-medicines-control-council-approves-tenofovirftc-for-prep","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/29570","title":{"rendered":"South African Medicines Control Council approves tenofovir\/FTC for PrEP"},"content":{"rendered":"<p><strong>Simon Collins, HIV i-Base<\/strong><\/p>\n<p><strong>On 3 December 2015 the South African Medicines Control Council (MCC) approved a fixed dose formulation of tenofovir DF\/FTC for HIV preexposure prophylaxis (PrEP).<\/strong><\/p>\n<p>Although limited details were provided, the MCC also requested a risk management plan, to collect safety data on side effects, and to report these every six months.<\/p>\n<p>The Medicines Control Council (MCC) is responsible for regulating all medicines and medical devices in South Africa.<\/p>\n<p>Reference:<\/p>\n<p>MCC press release. Medicines Control Council approves fixed-dose combination of tenofovir disoproxil fumarate and emtricitabine for pre-exposure prophylaxis of HIV. (3 December 2015).<br \/>\n<a href=\"http:\/\/www.mccza.com\">http:\/\/www.mccza.com<\/a><br \/>\n<a href=\"http:\/\/www.mccza.com\/documents\/2e4b3a5310.11_Media_release_ARV_FDC_PrEP_Nov15_v1.pdf\">http:\/\/www.mccza.com\/documents\/2e4b3a5310.11_Media_release_ARV_FDC_PrEP_Nov15_v1.pdf<\/a>\u00a0(PDF)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base On 3 December 2015 the South African Medicines Control Council (MCC) approved a fixed dose formulation of tenofovir DF\/FTC for HIV preexposure prophylaxis (PrEP). Although limited details were provided, the MCC also requested a risk management &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-29570","post","type-post","status-publish","format-standard","hentry","category-transmission-and-prevention"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/29570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=29570"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/29570\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=29570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=29570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=29570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}